These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 790087)

  • 1. Glucagon and lipoproteins.
    Eaton RP
    Metabolism; 1976 Nov; 25(11 Suppl 1):1415-7. PubMed ID: 790087
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic effects of glucagon in endogenous hypertriglyceridemia.
    Nosadini R; Soldà G; de Biasi F; Tiengo A
    Acta Diabetol Lat; 1978; 15(5-6):251-8. PubMed ID: 219650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cobalt chloride-induced hyperlipemia in the rat: effects on intermediary metabolism.
    Eaton RP
    Am J Physiol; 1972 Jun; 222(6):1550-7. PubMed ID: 4337789
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of insulin-resistance and free fatty acids on diurnal variations in glucose response to glucagon stimulation.
    Ciavarella A; Flammini M; Spoto M; Capelli M; Galuppi V; Vannini P
    J Endocrinol Invest; 1982; 5(6):379-82. PubMed ID: 6763055
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypolipemic glucagon activity in isolated liver of genetic or acquired hypertriglyceridemic rats.
    Nosadini R; Meneghel A; Del Prato S; Fedele D; Tiengo A
    Diabete Metab; 1980 Jun; 6(2):129-33. PubMed ID: 7409295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of insulin and glucagon on the liver.
    Rastogi GK
    J Assoc Physicians India; 1972 Nov; 20(11):859-66. PubMed ID: 4654918
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous glucagon regulation in genetically hyperlipemic obese rats.
    Eaton RP; Conway M; Schade DS
    Am J Physiol; 1976 May; 230(5):1336-41. PubMed ID: 1275076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenously administered fructose and glucose on splanchnic secretion of plasma triglycerides in hypertriglyceridemic men.
    Wolfe BM; Ahuja SP
    Metabolism; 1977 Sep; 26(9):963-78. PubMed ID: 197378
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of glucagon on plasma lipids in different types of primary hyperlipoproteinemia.
    Aubry F; Marcel YL; Davignon J
    Metabolism; 1974 Mar; 23(3):225-38. PubMed ID: 4813955
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 11. The enhancement of alimentary lipemia by ethanol in man.
    Wilson DE; Schreibman PH; Brewster AC; Arky RA
    J Lab Clin Med; 1970 Feb; 75(2):264-74. PubMed ID: 5414407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Flotation analysis studies of lipoproteins in correlation with the lipid pattern in essential hyperlipemia and diabetic metabolism status].
    Haller H; Hanefeld H; Kretschmar R; Unger E; Arnold F; Wagner B
    Schweiz Med Wochenschr; 1969 May; 99(22):813-5. PubMed ID: 5802001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of very-low-density lipoproteins in the pathogenesis of primary hypertriglyceridemia].
    Hanefeld M; Kretschmar R; Haller H; Unger E
    Z Gesamte Inn Med; 1970 Nov; 25(21):961-6. PubMed ID: 5523027
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IV hyperlipoproteinemia. A critical appraisal.
    Schonfeld G; Kudzma DJ
    Arch Intern Med; 1973 Jul; 132(1):55-62. PubMed ID: 4716427
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of high-carbohydrate diets on lipid and carbohydrate metabolism in the rat.
    Eaton RP; Kipnis DM
    Am J Physiol; 1969 Oct; 217(4):1160-8. PubMed ID: 5824318
    [No Abstract]   [Full Text] [Related]  

  • 17. The origin of hypertriglyceridemia in streptozotocin diabetic rats.
    Schnatz JD; Formaniak JM; Chlouverakis C
    Diabetologia; 1972 Apr; 8(2):125-30. PubMed ID: 4260605
    [No Abstract]   [Full Text] [Related]  

  • 18. Newly appreciated therapeutic effect of GLP-1 receptor agonists: reduction in postprandial lipemia.
    Bandsma RH; Lewis GF
    Atherosclerosis; 2010 Sep; 212(1):40-1. PubMed ID: 20638063
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased glucagon activity: A mechanism for genetic and acquired endogenous hyperlipaemia.
    Eaton RP; Schade DS; Conway M
    Lancet; 1974 Dec; 2(7896):1545-7. PubMed ID: 4140984
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.